Abstract:
A process for preparing an aqueous suspension of stable nonBeta -type crystals of a chloramphenicol high fatty acid esters by suspending non- Beta -type crystals of a chloramphenicol higher fatty acid ester with a sucrose fatty acid ester in water. Also provided herein is a stable pharmaceutical composition in the form of the aqueous suspension of the aforementioned components.
Abstract:
An aqueous suspension of chloramphenicol palmitate is prepared by melting chloramphenicol palmitate previously alone, mixing the melt with a hot aqueous solution containing one or more dispersing agents, cooling the dispersion, and then warming the same to prepare a bitterless aqueous suspension containing extremely fine and uniform alpha-type crystals of chloramphenicol palmitate having a high bioactivity.